State of play in amyotrophic lateral sclerosis genetics
暂无分享,去创建一个
[1] John Q. Trojanowski,et al. Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS , 2010, Nature.
[2] Leonard H van den Berg,et al. Evidence for an oligogenic basis of amyotrophic lateral sclerosis. , 2012, Human molecular genetics.
[3] A. Farmer,et al. Chromosome 9p21 in sporadic amyotrophic lateral sclerosis in the UK and seven other countries: a genome-wide association study , 2010, The Lancet Neurology.
[4] Robert H. Brown,et al. Amyotrophic Lateral Sclerosis-Associated SOD1 Mutant Proteins Bind and Aggregate with Bcl-2 in Spinal Cord Mitochondria , 2004, Neuron.
[5] Nick C Fox,et al. Pathogenic VCP Mutations Induce Mitochondrial Uncoupling and Reduced ATP Levels , 2013, Neuron.
[6] J. Haines,et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis , 1993, Nature.
[7] Janel O. Johnson,et al. Large proportion of amyotrophic lateral sclerosis cases in Sardinia due to a single founder mutation of the TARDBP gene. , 2011, Archives of neurology.
[8] L. Mulligan,et al. De Novo Mutation of GDNF, Ligand for the RET/GDNFR-α Receptor Complex, in Hirschsprung Disease , 1996 .
[9] A. Goris,et al. EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans , 2012, Nature Medicine.
[10] Patrizia Sola,et al. Exome Sequencing Reveals VCP Mutations as a Cause of Familial ALS , 2011, Neuron.
[11] A. Chiò,et al. A de novo missense mutation of the FUS gene in a “true” sporadic ALS case , 2011, Neurobiology of Aging.
[12] V. Meininger,et al. SOD1, ANG, VAPB, TARDBP, and FUS mutations in familial amyotrophic lateral sclerosis: genotype–phenotype correlations , 2010, Journal of Medical Genetics.
[13] M. Farrer,et al. DCTN1 mutations in Perry syndrome , 2009, Nature Genetics.
[14] Carl D Langefeld,et al. Age of onset of amyotrophic lateral sclerosis is modulated by a locus on 1p34.1 , 2013, Neurobiology of Aging.
[15] B. Traynor,et al. Genetics of sporadic amyotrophic lateral sclerosis. , 2007, Human molecular genetics.
[16] Pedagógia,et al. Cross Sectional Study , 2019 .
[17] A. Ludolph,et al. Amyotrophic lateral sclerosis. , 2012, Current opinion in neurology.
[18] P. Andersen,et al. Autosomal recessive adult-onset amyotrophic lateral sclerosis associated with homozygosity for Asp90Ala CuZn-superoxide dismutase mutation. A clinical and genealogical study of 36 patients. , 1996, Brain : a journal of neurology.
[19] R. Ritch,et al. Adult-Onset Primary Open-Angle Glaucoma Caused by Mutations in Optineurin , 2002, Science.
[20] S. Ennis,et al. A novel candidate region for ALS on chromosome 14q11.2 , 2004, Neurology.
[21] Peter K. Todd,et al. CGG Repeat-Associated Translation Mediates Neurodegeneration in Fragile X Tremor Ataxia Syndrome , 2013, Neuron.
[22] E. Bertini,et al. Infantile-onset ascending hereditary spastic paralysis is associated with mutations in the alsin gene. , 2002, American journal of human genetics.
[23] F. Marrosu,et al. Clinical characteristics of patients with familial amyotrophic lateral sclerosis carrying the pathogenic GGGGCC hexanucleotide repeat expansion of C9ORF72. , 2012, Brain : a journal of neurology.
[24] G. Crabtree,et al. Exome sequencing to identify de novo mutations in sporadic ALS trios , 2013, Nature Neuroscience.
[25] Edwin Cuppen,et al. Angiogenin variants in Parkinson disease and amyotrophic lateral sclerosis , 2011, Annals of neurology.
[26] R. Ophoff,et al. ITPR2 as a susceptibility gene in sporadic amyotrophic lateral sclerosis: a genome-wide association study , 2007, The Lancet Neurology.
[27] S. Hadano,et al. A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2 , 2001, Nature Genetics.
[28] Z. Wszolek,et al. De novo truncating FUS gene mutation as a cause of sporadic amyotrophic lateral sclerosis , 2010, Human mutation.
[29] D. Labuda,et al. Mutations in senataxin responsible for Quebec cluster of ataxia with neuropathy , 2005, Annals of neurology.
[30] Kuixing Zhang,et al. Whole-genome analysis of sporadic amyotrophic lateral sclerosis. , 2007, The New England journal of medicine.
[31] J. Haines,et al. Mutations in UBQLN2 cause dominant X-linked juvenile and adult onset ALS and ALS/dementia , 2011, Nature.
[32] Ewout J N Groen,et al. Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis , 2009, Nature Genetics.
[33] N. Ertekin-Taner,et al. Novel p.Ile151Val mutation in VCP in a patient of African American descent with sporadic ALS , 2011, Neurology.
[34] V. Meininger,et al. Guidelines for the preclinical in vivo evaluation of pharmacological active drugs for ALS/MND: Report on the 142nd ENMC international workshop , 2007, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.
[35] V. Meininger,et al. Mutations in SQSTM1 encoding p62 in amyotrophic lateral sclerosis: genetics and neuropathology , 2013, Acta Neuropathologica.
[36] Takeo Kato,et al. Mutations of optineurin in amyotrophic lateral sclerosis , 2010, Nature.
[37] S. Ajroud‐Driss,et al. SQSTM1 mutations in familial and sporadic amyotrophic lateral sclerosis. , 2011, Archives of neurology.
[38] P. S. St George-Hyslop,et al. SQSTM1 mutations in frontotemporal lobar degeneration and amyotrophic lateral sclerosis , 2012, Neurology.
[39] G. Rouleau,et al. Analysis of the UNC13A gene as a risk factor for sporadic amyotrophic lateral sclerosis. , 2010, Archives of neurology.
[40] Bruce L. Miller,et al. Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis , 2006, Science.
[41] T. Gillingwater,et al. A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. , 2004, American journal of human genetics.
[42] S. C. Chafe,et al. Mutations in the Profilin 1 Gene Cause Familial Amyotrophic Lateral Sclerosis , 2012, Nature.
[43] A. Brice,et al. Mutations in the PFN1 gene are not a common cause in patients with amyotrophic lateral sclerosis and frontotemporal lobar degeneration in France , 2013, Neurobiology of Aging.
[44] Janel O. Johnson,et al. Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study , 2012, The Lancet Neurology.
[45] N. Morton,et al. Segregation analysis of peripheral neurofibromatosis (NF1). , 1990, Journal of medical genetics.
[46] Sonja W. Scholz,et al. A two-stage genome-wide association study of sporadic amyotrophic lateral sclerosis. , 2009, Human molecular genetics.
[47] J L Haines,et al. Supporting Online Material Materials and Methods Figs. S1 to S7 Tables S1 to S4 References Mutations in the Fus/tls Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis , 2022 .
[48] P. Tacconi,et al. ALS/FTD phenotype in two Sardinian families carrying both C9ORF72 and TARDBP mutations , 2012, Journal of Neurology, Neurosurgery & Psychiatry.
[49] David Heckerman,et al. Chromosome 9p21 in amyotrophic lateral sclerosis in Finland: a genome-wide association study , 2010, The Lancet Neurology.
[50] E. Laplantine,et al. Toward an integrative view of Optineurin functions , 2012, Cell cycle.
[51] M. Swash,et al. Controversies and priorities in amyotrophic lateral sclerosis , 2013, The Lancet Neurology.
[52] E. Mohammadi,et al. Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.
[53] A. Al-Chalabi,et al. New VAPB deletion variant and exclusion of VAPB mutations in familial ALS , 2008, Neurology.
[54] J. Collinge,et al. ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B) , 2006, Neurology.
[55] Claire L. Simpson,et al. Reduced expression of the Kinesin-Associated Protein 3 (KIFAP3) gene increases survival in sporadic amyotrophic lateral sclerosis , 2009, Proceedings of the National Academy of Sciences.
[56] C. Tanner,et al. A High-Density Genome-Wide Association Screen of Sporadic ALS in US Veterans , 2012, PloS one.
[57] Nick C Fox,et al. Large C9orf72 hexanucleotide repeat expansions are seen in multiple neurodegenerative syndromes and are more frequent than expected in the UK population. , 2013, American journal of human genetics.
[58] A. Chiò,et al. Genetic counselling in ALS: facts, uncertainties and clinical suggestions , 2013, Journal of Neurology, Neurosurgery & Psychiatry.
[59] S. Donato. Faculty Opinions recommendation of An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study. , 2013 .
[60] J. Powell,et al. No association of DPP6 with amyotrophic lateral sclerosis in an Italian population , 2011, Neurobiology of Aging.
[61] A. Pestronk,et al. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein , 2004, Nature Genetics.
[62] Liangdan Sun,et al. Genome-wide association analyses in Han Chinese identify two new susceptibility loci for amyotrophic lateral sclerosis , 2013, Nature Genetics.
[63] Paul G. Ince,et al. Mutations in CHMP2B in Lower Motor Neuron Predominant Amyotrophic Lateral Sclerosis (ALS) , 2010, PloS one.
[64] H. Horvitz,et al. Epidemiology of mutations in superoxide dismutase in amyotrophic lateal sclerosis , 1997, Annals of neurology.
[65] A Al-Chalabi,et al. Distinct cerebral lesions in sporadic and 'D90A' SOD1 ALS: studies with [11C]flumazenil PET. , 2005, Brain : a journal of neurology.
[66] A. Singleton,et al. Amyotrophic Lateral Sclerosis: An Emerging Era of Collaborative Gene Discovery , 2007, PloS one.
[67] G. Parkinson,et al. C9orf72 hexanucleotide repeat associated with amyotrophic lateral sclerosis and frontotemporal dementia forms RNA G-quadruplexes , 2012, Scientific Reports.
[68] R. Gross. Extensive genetics of ALS: A population-based study in Italy , 2012 .
[69] F. Pasquier,et al. C9orf72 repeat expansions are a rare genetic cause of parkinsonism. , 2013, Brain : a journal of neurology.
[70] William D Fraser,et al. Genome wide association study identifies variants at CSF1, OPTN and TNFRSF11A as genetic risk factors for Paget’s disease of bone , 2010, Nature Genetics.
[71] Frank Baas,et al. Genetic variation in DPP6 is associated with susceptibility to amyotrophic lateral sclerosis , 2008, Nature Genetics.
[72] John P A Ioannidis,et al. Meta-analysis in genome-wide association studies. , 2009, Pharmacogenomics.
[73] Xun Hu,et al. Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6 , 2009, Science.
[74] Orla Hardiman,et al. “True” sporadic ALS associated with a novel SOD‐1 mutation , 2002, Annals of neurology.
[75] A. Chiò,et al. Amyotrophic lateral sclerosis-frontotemporal lobar dementia in 3 families with p.Ala382Thr TARDBP mutations. , 2010, Archives of neurology.
[76] Jacques P. Brown,et al. Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of bone. , 2002, American journal of human genetics.
[77] David Heckerman,et al. A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD , 2011, Neuron.
[78] Bruce L. Miller,et al. Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS , 2011, Neuron.
[79] S. Ennis,et al. ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis , 2006, Nature Genetics.
[80] A. Singleton,et al. Repeat expansion in C9ORF72 in Alzheimer's disease. , 2012, The New England journal of medicine.
[81] A. Chiò,et al. Prevalence of SOD1 mutations in the Italian ALS population , 2008, Neurology.
[82] E. Brustein,et al. FUS and TARDBP but Not SOD1 Interact in Genetic Models of Amyotrophic Lateral Sclerosis , 2011, PLoS genetics.
[83] V. Meininger,et al. UBQLN2 mutations are rare in French and French–Canadian amyotrophic lateral sclerosis , 2012, Neurobiology of Aging.
[84] B. Dubois,et al. Expanded ATXN2 CAG repeat size in ALS identifies genetic overlap between ALS and SCA2 , 2011, Neurology.
[85] Shin J. Oh,et al. Mutant dynactin in motor neuron disease , 2003, Nature Genetics.
[86] Antonio Gambardella,et al. Amyotrophic lateral sclerosis: a new missense mutation in the SOD1 gene , 2013, Neurobiology of Aging.
[87] J. Alappat. ETHNIC VARIATION IN THE INCIDENCE OF ALS: A SYSTEMATIC REVIEW , 2007, Neurology.
[88] 田原 康玄,et al. 生活習慣病とgenome-wide association study , 2015 .
[89] Michael Benatar,et al. Prion-like domain mutations in hnRNPs cause multisystem proteinopathy and ALS , 2013, Nature.
[90] Holger Hummerich,et al. Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia , 2005, Nature Genetics.
[91] Janel O. Johnson,et al. Kinesin-associated protein 3 (KIFAP3) has no effect on survival in a population-based cohort of ALS patients , 2010, Proceedings of the National Academy of Sciences.
[92] Ewout J. N. Groen,et al. VCP mutations in familial and sporadic amyotrophic lateral sclerosis , 2012, Neurobiology of Aging.
[93] Orla Hardiman,et al. A genome-wide association study of sporadic ALS in a homogenous Irish population. , 2007, Human molecular genetics.
[94] P. Andersen. Amyotrophic lateral sclerosis associated with mutations in the CuZn superoxide dismutase gene , 2006, Current neurology and neuroscience reports.
[95] Sonja W. Scholz,et al. Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data , 2007, The Lancet Neurology.
[96] Mohamad Saad,et al. Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies , 2011, The Lancet.
[97] A. Farmer,et al. Chromosome 9p21 in sporadic amyotrophic lateral sclerosis in the UK and seven other countries: a genome-wide association study , 2010, The Lancet Neurology.
[98] L. Mulligan,et al. De novo mutation of GDNF, ligand for the RET/GDNFR-alpha receptor complex, in Hirschsprung disease. , 1996, Human molecular genetics.
[99] Robert H. Brown,et al. Deleterious variants of FIG4, a phosphoinositide phosphatase, in patients with ALS. , 2009, American journal of human genetics.
[100] A. Pestronk,et al. An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study , 2013, The Lancet Neurology.
[101] Xun Hu,et al. TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis , 2008, Science.
[102] J. Trojanowski,et al. Pathological TDP‐43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations , 2007, Annals of neurology.
[103] Nick C Fox,et al. Common variants in ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer’s disease , 2011, Nature Genetics.
[104] E. Rogaeva,et al. Hypermethylation of the CpG island near the G4C2 repeat in ALS with a C9orf72 expansion. , 2013, American journal of human genetics.
[105] E. Kremmer,et al. The C9orf72 GGGGCC Repeat Is Translated into Aggregating Dipeptide-Repeat Proteins in FTLD/ALS , 2013, Science.
[106] John W Griffin,et al. DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). , 2004, American journal of human genetics.
[107] Stephanie C Huelga,et al. Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs , 2012, Nature Neuroscience.
[108] C. Shaw,et al. Familial amyotrophic lateral sclerosis is associated with a mutation in D-amino acid oxidase , 2010, Proceedings of the National Academy of Sciences.